1. As the technology is NOT approved for human use, what percentage of the 200 possible customers require stem cells for human trials only? or are working on human therapy's?
2. If the technology is not approved by any meaningful authority for humans, then why would any pharma jeopardize their whole drug trial (expensive and many years) to use a technology from the outset that could well see FDA state that any trial is flawed using this technology as this stem cell technology is not approved nor proven for human use.
1. As the technology is NOT approved for human use, what...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $41.55M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $13.05K | 56.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 48790 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 20513 | 1 |
View Market Depth
| Last trade - 11.59am 31/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |